BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10391554)

  • 21. Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study.
    Malcherczyk D; Heyse TJ; El-Zayat BF; Kunzke V; Moll R; Fuchs-Winkelmann S; Paletta JRJ
    BMC Musculoskelet Disord; 2018 Jan; 19(1):9. PubMed ID: 29316907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.
    Verdegaal SH; Brouwers HF; van Zwet EW; Hogendoorn PC; Taminiau AH
    J Bone Joint Surg Am; 2012 Jul; 94(13):1201-7. PubMed ID: 22760388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of matrix metalloproteinase-1, -3, and -13 in naturally occurring cartilaginous tumors of dogs.
    Kuroki K; Kreeger JM; Cook JL; Tomlinson JL; Johnson GC; Pace LW; Turnquist SE; Turk JR; Ramos JA; Miller MA
    Am J Vet Res; 2002 Sep; 63(9):1285-91. PubMed ID: 12224862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary tumours of ribs and sternum.
    Tala P; Koikkalainen K
    Ann Chir Gynaecol Fenn; 1967; 56(2):223-32. PubMed ID: 6065331
    [No Abstract]   [Full Text] [Related]  

  • 25. A review of the behaviour of chondrosarcoma of bone.
    Sanerkin NG; Gallagher P
    J Bone Joint Surg Br; 1979 Nov; 61-B(4):395-400. PubMed ID: 500746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female gender in the hormonally active age group plays a major role in high-grade chondrosarcoma survival.
    Laitinen MK; Albergo JI; Stevenson JD; Farfalli GL; Aponte-Tinao LA; Grimer RJ; Jeys LM; Parry MC
    Acta Oncol; 2020 Feb; 59(2):242-246. PubMed ID: 31769322
    [No Abstract]   [Full Text] [Related]  

  • 27. Collagenase specificity in chondrosarcoma metastasis.
    Scully SP; Berend KR; Qi WN; Harrelson JM
    Braz J Med Biol Res; 1999 Jul; 32(7):885-9. PubMed ID: 10454748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment of locally recurrent chondrosarcoma: Is extensive further surgery justified?
    Streitbuerger A; Ahrens H; Gosheger G; Henrichs M; Balke M; Dieckmann R; Hardes J
    J Bone Joint Surg Br; 2012 Jan; 94(1):122-7. PubMed ID: 22219259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma.
    Jiang X; Dutton CM; Qi Wn; Block JA; Brodt P; Durko M; Scully SP
    J Orthop Res; 2003 Nov; 21(6):1063-70. PubMed ID: 14554220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification for central conventional chondrosarcoma of bone: A novel system predicting risk of metastasis and death in the Cancer Registry of Norway cohort.
    Thorkildsen J; Taksdal I; Bjerkehagen B; Norum OJ; Myklebust TA; Zaikova O
    J Surg Oncol; 2020 Jun; 121(7):1115-1125. PubMed ID: 32141094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Giant chondrosarcoma of the scapula].
    Zisman IF; Kukuté BG
    Khirurgiia (Mosk); 1975 Sep; (9):135-6. PubMed ID: 1228307
    [No Abstract]   [Full Text] [Related]  

  • 32. [Poorly differentiated ("dedifferentiated") chondrosarcoma].
    Petrovichev NN; Eremina LA; Khmelev LA; Kasumov NV
    Vopr Onkol; 1984; 30(1):8-13. PubMed ID: 6695530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion.
    Yuan J; Dutton CM; Scully SP
    J Orthop Res; 2005 Nov; 23(6):1467-74. PubMed ID: 15927440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor prognostic factors in chondrosarcoma of the locomotor system. Apropos of 180 cases].
    Ucla E; Tomeno B; Forest M
    Rev Chir Orthop Reparatrice Appar Mot; 1991; 77(5):301-11. PubMed ID: 1836882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chondroma and chondrosarcoma.
    Kitagawa T
    Kumamoto Med J; 1974 Mar; 27(1):55-65. PubMed ID: 4437132
    [No Abstract]   [Full Text] [Related]  

  • 36. Pelvic chondrosarcomas: surgical treatment options.
    Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between the structure and clinical course of chondrosarcomas].
    Ivanenko SN
    Arkh Patol; 1980; 42(7):63-7. PubMed ID: 7417025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinico-morphological characteristics of bone chondrosarcomas].
    Petrovichev NN; Eremina LA; Kasumov NV
    Vopr Onkol; 1984; 30(4):14-20. PubMed ID: 6730402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chondrosarcomas of digits: are they really malignant?
    Mankin HJ
    Cancer; 1999 Nov; 86(9):1635-7. PubMed ID: 10547534
    [No Abstract]   [Full Text] [Related]  

  • 40. Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line.
    Lai TJ; Hsu SF; Li TM; Hsu HC; Lin JG; Hsu CJ; Chou MC; Lee MC; Yang SF; Fong YC
    Acta Pharmacol Sin; 2007 Aug; 28(8):1231-5. PubMed ID: 17640487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.